NEW YORK (GenomeWeb News) — When the National Human Genome Research Institute announced its grant awards this fall for 11 research groups working on innovative sequencing technologies, one big name stuck out: General Electric.
 
The company, whose GE Healthcare division has been selling Amersham Biosciences’ MegaBace sequencing technology since GE acquired Amersham in early 2004, has until now remained quiet about whether it is pursuing next-generation sequencing.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.